MRC CSO Social and Public Health Sciences Unit, Glasgow, UK.
BMC Infect Dis. 2011 Aug 24;11:226. doi: 10.1186/1471-2334-11-226.
In the United Kingdom (UK) in September 2008, school nurses began delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study offers insights from school nurses' perspectives and experiences of delivering this new vaccination programme.
Thirty in-depth telephone interviews were conducted with school nurses working across the UK between September 2008 and May 2009. This time period covers the first year of the HPV vaccination programme in schools. School nurses were recruited via GP practices, the internet and posters targeted at school nurse practitioners.
All the school nurses spoke of readying themselves for a deluge of phone calls from concerned parents, but found that in fact few parents telephoned to ask for more information or express their concerns about the HPV vaccine. Several school nurses mentioned a lack of planning by policy makers and stated that at its introduction they felt ill prepared. The impact on school nurses' workload was spoken about at length by all the school nurses. They believed that the programme had vastly increased their workload leading them to cut back on their core activities and the time they could dedicate to offering support to vulnerable pupils.
Overall the first year of the implementation of the HPV vaccination programme in the UK has exceeded school nurses' expectations and some of its success may be attributed to the school nurses' commitment to the programme. It is also the case that other factors, including positive newsprint media reporting that accompanied the introduction of the HPV vaccination programme may have played a role. Nevertheless, school nurses also believed that the programme had vastly increased their workload leading them to cut back on their core activities and as such they could no longer dedicate time to offer support to vulnerable pupils. This unintentional aspect of the programme may be worthy of further exploration.
2008 年 9 月,英国开始由学校护士为 12 至 13 岁的女孩接种 HPV 疫苗。本研究从学校护士的角度出发,探讨他们对这一新疫苗接种项目的看法和经验。
2008 年 9 月至 2009 年 5 月,在英国各地,对 30 名学校护士进行了深入的电话访谈。这段时间涵盖了学校 HPV 疫苗接种项目的第一年。学校护士通过全科医生诊所、互联网和针对学校护士从业者的海报被招募。
所有的学校护士都表示,他们已经准备好应对大量忧心忡忡的家长打来的电话,但实际上很少有家长打电话来询问更多信息或表达他们对 HPV 疫苗的担忧。几位学校护士提到了政策制定者缺乏规划,并表示在项目推出时,他们感到准备不足。所有的学校护士都详细地谈到了该项目对他们工作量的影响。他们认为,该项目大大增加了他们的工作量,导致他们削减了核心活动,并减少了为弱势学生提供支持的时间。
总的来说,英国 HPV 疫苗接种项目实施的第一年超出了学校护士的预期,其成功的部分原因可能归因于学校护士对该项目的承诺。此外,包括 HPV 疫苗接种项目推出时伴随的积极新闻报道等其他因素也可能发挥了作用。然而,学校护士也认为,该项目大大增加了他们的工作量,导致他们削减了核心活动,因此他们无法再花时间为弱势学生提供支持。该项目的这一意外方面可能值得进一步探讨。